|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 412.90 INR | +0.47% |
|
-2.49% | +0.27% |
| 08-03 | Aarti Drugs Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 07-31 | Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 37.51B 394M 342M 320M 293M 553M 560M 3.74B 1.47B 18.74B 1.48B 1.45B 62.37B | P/E 2026 |
15x | P/E 2027 * | 18.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.51B 394M 342M 320M 293M 553M 560M 3.74B 1.47B 18.74B 1.48B 1.45B 62.37B | EV / Sales 2026 |
1.14x | EV / Sales 2027 * | 1.27x |
| Free-Float |
39.83% | Yield 2026 * |
0.97% | Yield 2027 * | 1.44% |
Last Transcript: Aarti Drugs Limited
| 22-12-28 | Aarti Drugs : Loss of Share Certificates | PU |
| 22-07-10 | Aarti Drugs : Newspaper Advertisements | PU |
| 1 day | +0.49% | ||
| 1 week | -2.49% | ||
| Current month | -2.49% | ||
| 1 month | +6.33% | ||
| 3 months | +3.82% | ||
| 6 months | +9.62% | ||
| Current year | +0.27% |
| 1 week | 404.65 |  | 449 |
| 1 month | 383 | | 449 |
| Current year | 318.6 | | 449 |
| 1 year | 318.6 | | 534.15 |
| 3 years | 312.5 | | 634.9 |
| 5 years | 310.8 | | 669.4 |
| 10 years | 104.82 | | 1,025 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 80 | - | |
| Chief Executive Officer | 79 | 2007-05-31 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 43 | 2012-07-05 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 79 | 2014-03-31 | |
| Director/Board Member | 62 | 2007-05-31 | |
| Chairman | 80 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | -2.49% | -18.33% | -26.27% | 394M | |
| +1.89% | +3.20% | +59.70% | +165.18% | 1,062B | |
| -0.24% | +0.45% | +50.64% | +52.02% | 619B | |
| -0.95% | -5.26% | +24.23% | +65.08% | 431B | |
| +2.30% | +5.46% | +49.70% | +40.80% | 358B | |
| +0.81% | -0.08% | +35.95% | +40.79% | 293B | |
| +1.28% | -4.70% | +9.94% | +10.58% | 247B | |
| -0.73% | +4.44% | +42.22% | +66.41% | 219B | |
| +4.72% | -0.07% | -0.83% | -43.87% | 200B | |
| -0.68% | -0.32% | +18.66% | +66.32% | 162B | |
| Average | +0.61% | -1.75% | +27.19% | +43.70% | 359.27B | |
| Weighted average by Cap. | +0.17% | -0.83% | +41.23% | +78.34% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 26.07B 274M 237M 222M 203M 384M 389M 2.6B 1.02B 13.02B 1.03B 1.01B 43.35B | 29.45B 309M 268M 251M 230M 434M 440M 2.94B 1.15B 14.72B 1.16B 1.14B 48.98B |
| Net income | 1.82B 19.13M 16.6M 15.54M 14.22M 26.84M 27.19M 182M 71.36M 910M 71.81M 70.25M 3.03B | 2.15B 22.59M 19.6M 18.36M 16.79M 31.7M 32.12M 215M 84.28M 1.08B 84.82M 82.98M 3.58B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | ₹412.90 | +0.47% | 1,847 |
| 26-08-06 | ₹410.95 | -0.29% | 5,875 |
| 26-08-05 | ₹412.15 | -0.52% | 9,023 |
| 26-08-04 | ₹414.30 | +1.77% | 5,284 |
| 26-08-03 | ₹407.10 | -3.87% | 52,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AARTIDRUGS Stock
Select your edition
All financial news and data tailored to specific country editions
